You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Novel Apoptosis Assay with Antibodies to ssDNA

    SBC: APOSTAIN, INC.            Topic: N/A

    DESCRIPTION (Provided by Applicant): Work performed during the Phase I of this project has demonstrated that formamide induces selective denaturation of DNA in apoptotic cells. This novel effect of formamide on the stability of apoptotic DNA combined with the detection of denatured DNA with monoclonal antibody (MAb)against single-stranded DNA, has made it possi ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  2. Assessment of Team Competencies

    SBC: FLORIDA MAXIMA CORP            Topic: N/A

    The military's traditional reliance on teams to perform vital missions has become even more pronounced as the military transforms itself into a lighter, more mobile, and more deployable force. Although the military does an exceptional job of imparting thetechnical skills that are required for mission performance, considerably less progress has been made in understanding other factors that make a

    STTR Phase II 2001 Department of DefenseArmy
  3. Audio-Vestibular Testing for Bedside/Other Applications

    SBC: INTELLIGENT HEARING SYSTEMS CORP            Topic: N/A

    DESCRIPTION: (Adapted from applicant's abstract): A potentially effective way of limiting or preventing drug-induced cochleo- and vestibulo-ototoxicity is monitoring during treatment. However, practical, cost-effective, monitoring programs are difficult to establish due to impractical instrumentation. Current practices also tend to neglect the balance system. Research ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Enteric Elimination and Degradation of Oxalic Acid

    SBC: IXION BIOTECHNOLOGY, INC.            Topic: N/A

    Approximately one million cases of stone disease are diagnosed in the United States every year and hyperoxaluria is considered to be a major risk factor. Our goal is to reduce the burden of oxalate excretion by the kidneys before the onset of renal failure caused by the oxalate-induced insults of hyperoxaluria, oxalate crystal deposition in tissue, and the formation of calcium oxalate stones. The ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  5. M3 RECEPTOR--DIAGNOSTIC MARKER FOR SJOGREN'S SYNDROME

    SBC: IXION BIOTECHNOLOGY, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Sjogren's syndrome is a human autoimmune disease of the salivary and lacrimal glands that results in a debilitating xerostomia (dry mouth) and xerophthalmia (dry eyes). This syndrome may present as either a primary autoimmune disease or as a secondary autoimmune disease most often concomitant with other connective tissue diseases or diabetes. Although classi ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  6. Magnetic Resonance Force Microscopy

    SBC: Cryo Industries of America, Inc.            Topic: N/A

    This Small Business Technology Transfer Research Phase II project capitalizes on a unique combination of technical expertise developed at Cornell University, SC Solutions, and Cryo Industries of America to produce a powerful new type of scanned probemicroscope.The magnetic resonance force microscope is a sensitive new technique for detecting nuclear magnetic (and unpaired electrons). In this pro ...

    STTR Phase II 2003 Department of DefenseArmy
  7. Remote Detection of Riverine Traffic

    SBC: Custom Manufacturing & Engineering, Inc.            Topic: ARMY03T18

    During Phase I, research and experiments were conducted and a conceptual design was completed for a Remote Marine & Watercraft Surveillance System (RMWSS). RMWSS will detect powered and unpowered watercraft on riverine and inland waterways in South America. Based upon Phase I results, CME will develop an innovative system prototype that includes active and passive sensors to detect watercraft in d ...

    STTR Phase II 2004 Department of DefenseArmy
  8. Cytochlor/cytofluor: New Tumor Targeted Radiosensitizer

    SBC: HALOGENETICS            Topic: N/A

    DESCRIPTION (provided by applicant): Cytochlor Technology is about to enter a Phase I trial as a radiosensitizer of tumors of the oral cavity and oropharynx with NCI supervision. Our objective is to demonstrate Cytochlor's safety, selectivity and possible efficacy (although efficacy is not the goal of a Phase I trial). Our goal is to move Cytochlor Technology to a mutliinstitutional Phase II clini ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Evolutionary Analysis of Protein using HyperChem

    SBC: HYPERCUBE            Topic: N/A

    DESCRIPTION (provided by applicant): At the end of Phase II, we will launch a new commercial product: HYPERPROTEIN. HYPERPROTEIN will be built on an existing software platform, HYPERCHEM, now in its commercial Version 7.5. HYPERCHEM is used in both education and industry to apply molecular modeling and computational chemistry to molecules. The feasibility of placing the HYPERPROTEIN product on th ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Nonpeptide Somatostatin Agonists for Retinopathy

    SBC: RFE PHARMA, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR), the leading cause of adult blindness in the United States, is characterized by aberrant neovascularization ultimately leading to blindness. Similarly, choroidal neovascularization is seen in age-related macular degeneration (ARMD), which is the leading cause of blindness in the elderly. Currently, there is no drug treatment for either ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government